Tim Knotnerus, Founder of AgomAb Therapeutics

Tim Knotnerus is the founder of AgomAb Therapeutics. AgomAb Therapeutics has raised $189M in total funding. Latest round: Series D. Based in Ghent, Belgium.

About Tim Knotnerus

Tim Knotnerus is the Chief Executive Officer at AgomAb Therapeutics, a company focused on developing therapies to treat fibrosis and regenerate tissue in chronic conditions like fibrostenosing Crohn's disease and idiopathic pulmonary fibrosis. AgomAb has successfully raised significant funding, including a $100 million Series C in 2023 and an $89 million Series D in 2024, to advance its pipeline of drug candidates.

Tim Knotnerus at a glance

More founders in Ghent, Belgium (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library